{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-08-24T12:20:25.131623+00:00",
  "news": [
    {
      "title": "LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery – Amgen - Oncodaily",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE8zckFfVkhmNy12ZE5SNXRUYkt6MXhzN3Z2ZmFWY25fa0p0RTdZMWZTZ1B1VklISUdyaW5RYWEwVmhJd09lbXNHYUpIdElpMlQ0Sm1J?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE8zckFfVkhmNy12ZE5SNXRUYkt6MXhzN3Z2ZmFWY25fa0p0RTdZMWZTZ1B1VklISUdyaW5RYWEwVmhJd09lbXNHYUpIdElpMlQ0Sm1J?oc=5\" target=\"_blank\">LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery – Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Oncodaily</font>",
      "published": "2025-08-24T02:35:18+00:00",
      "source": "Oncodaily"
    },
    {
      "title": "Amgen overturns $50m patent damages; China extraterritorial ruling exclusive; UPC flexes long-arm jurisdiction; 3GPP RAN2 chair interview; American brain drain; plus much more - IAM Media",
      "link": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxPV3Z3RXZIek5UNVF5a05lcEVBb3JKNEg2d09EbVcxdHQxSUd5WEdPUkdzRWFWV0s3SWJDNzVsdzhqZDI0ZzdiaWM2ZGpzVi1PY0JYWXZQMUJ1MThjcU1jbnhEd2hBVHJvUXFfN3FBYktuU2R0S0hRY1pPUF9oT2haYWY4LXp2dE1feEJIX0VZSGxRSFBHLW1PXzBDU2pqSVlDeDZnaENRdXNWZmZrbV9SVGlFd2VGd1h1R0RjTU1QeHFrdlZTYnptWGdzTFVnVnBEUGN1SDZTS08xLUlGRlZ6UmxRWnNvbXltVEhkT3ZLX2Q?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi8AFBVV95cUxPV3Z3RXZIek5UNVF5a05lcEVBb3JKNEg2d09EbVcxdHQxSUd5WEdPUkdzRWFWV0s3SWJDNzVsdzhqZDI0ZzdiaWM2ZGpzVi1PY0JYWXZQMUJ1MThjcU1jbnhEd2hBVHJvUXFfN3FBYktuU2R0S0hRY1pPUF9oT2haYWY4LXp2dE1feEJIX0VZSGxRSFBHLW1PXzBDU2pqSVlDeDZnaENRdXNWZmZrbV9SVGlFd2VGd1h1R0RjTU1QeHFrdlZTYnptWGdzTFVnVnBEUGN1SDZTS08xLUlGRlZ6UmxRWnNvbXltVEhkT3ZLX2Q?oc=5\" target=\"_blank\">Amgen overturns $50m patent damages; China extraterritorial ruling exclusive; UPC flexes long-arm jurisdiction; 3GPP RAN2 chair interview; American brain drain; plus much more</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">IAM Media</font>",
      "published": "2025-08-24T10:35:42+00:00",
      "source": "IAM Media"
    },
    {
      "title": "Venture Visionary Partners LLC Has $6.83 Million Stock Position in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQVUhnSi13cXNNNFdjMlpPQzVyZ0JKMDA0NHZKWlE3cjhtYURzemIzbzFoUEh2b1B6c1ZHYkVmc3FDUEp5SnNfYXBsNmtycTB4bEczQU10cDhfbUZGS2lZaWJKSzN2WTZ0cnBaS2hSU3Y5emhjaElPYWlwUEFQdVo2U2VFVlRsdU9iRGt5ZjlCQzdTLVktaW9ka19wX3hyOHhzWXpMV0FPVHpXa2Mtb2trLTBkM3l2cEFwNFRtaGhOZ0hkeWNOVU00Rg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQVUhnSi13cXNNNFdjMlpPQzVyZ0JKMDA0NHZKWlE3cjhtYURzemIzbzFoUEh2b1B6c1ZHYkVmc3FDUEp5SnNfYXBsNmtycTB4bEczQU10cDhfbUZGS2lZaWJKSzN2WTZ0cnBaS2hSU3Y5emhjaElPYWlwUEFQdVo2U2VFVlRsdU9iRGt5ZjlCQzdTLVktaW9ka19wX3hyOHhzWXpMV0FPVHpXa2Mtb2trLTBkM3l2cEFwNFRtaGhOZ0hkeWNOVU00Rg?oc=5\" target=\"_blank\">Venture Visionary Partners LLC Has $6.83 Million Stock Position in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-08-24T09:56:45+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "From Blocking to Locking: Rethinking How Amgen Intervenes in Disease - Amgen",
      "link": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQTlU1T1JpODczeU91amV6b0dBc0JMbG1iR1hwM3diMl9kdUtvTFVlWUctc1VyZmJWOUdKWWxaSDJzOUtFVWI5amwyeGNNYmpldnFBdndJdFVwRXUxOGFoMzZyTDBTRW5tSlZ6WEIzUjZMdUhJZ3lJbm5Ua0psRnFiMC1wTV9namRHanVrbF9hVDh4dm8zaVhMelg1ZHJyejBkTjB0WWkxZ252U28?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQTlU1T1JpODczeU91amV6b0dBc0JMbG1iR1hwM3diMl9kdUtvTFVlWUctc1VyZmJWOUdKWWxaSDJzOUtFVWI5amwyeGNNYmpldnFBdndJdFVwRXUxOGFoMzZyTDBTRW5tSlZ6WEIzUjZMdUhJZ3lJbm5Ua0psRnFiMC1wTV9namRHanVrbF9hVDh4dm8zaVhMelg1ZHJyejBkTjB0WWkxZ252U28?oc=5\" target=\"_blank\">From Blocking to Locking: Rethinking How Amgen Intervenes in Disease</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-08-21T18:50:33+00:00",
      "source": "Amgen"
    },
    {
      "title": "Custom strategy builders for tracking Amgen Inc. - Market Volume Report & High Win Rate Trade Tips - Newser",
      "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPbF9hYm04ZjRJYmVDWm4zWUxMOEhmUjItbGxRNk9IbzRRa2hZdkZlMzREUXAxaFJzYzlvbHI1ejdjZDJOSmVLcFBYeWJzVXg4QTM4eGUza3pwNkhQUFpwa0JkM1hMVF96T1oxdnZGOVNWZlphM2QwMWt0ZU5vTm9aT1dzcU13X05uSXc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxPbF9hYm04ZjRJYmVDWm4zWUxMOEhmUjItbGxRNk9IbzRRa2hZdkZlMzREUXAxaFJzYzlvbHI1ejdjZDJOSmVLcFBYeWJzVXg4QTM4eGUza3pwNkhQUFpwa0JkM1hMVF96T1oxdnZGOVNWZlphM2QwMWt0ZU5vTm9aT1dzcU13X05uSXc?oc=5\" target=\"_blank\">Custom strategy builders for tracking Amgen Inc. - Market Volume Report & High Win Rate Trade Tips</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>",
      "published": "2025-08-23T15:06:33+00:00",
      "source": "Newser"
    },
    {
      "title": "Amgen Stock (AMGN) Opinions on Dividend Announcement and Clinical Trial Success - Quiver Quantitative",
      "link": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPYkJiUWZTb2NQOWFQalFRUzRlSlcxV2JvYUp2WTByMVpkTUNqcXlmNlR1SmNENTB4dTBLSjZuOVJwbFI0VElVSWZrNUdDRExXNDFfemQtUnhlTzV3T2FlLXhyUVg2U1JUZzFpaS05U3B2SlJKanhJV0J4TV9VaTdscHhTaWpRMElDZHkyWko2d2pEeXVUMjJUdUNzWm9ObXFHcmlQN0FPUUs3LU84VVNPc1dtTXR1bjA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitwFBVV95cUxPYkJiUWZTb2NQOWFQalFRUzRlSlcxV2JvYUp2WTByMVpkTUNqcXlmNlR1SmNENTB4dTBLSjZuOVJwbFI0VElVSWZrNUdDRExXNDFfemQtUnhlTzV3T2FlLXhyUVg2U1JUZzFpaS05U3B2SlJKanhJV0J4TV9VaTdscHhTaWpRMElDZHkyWko2d2pEeXVUMjJUdUNzWm9ObXFHcmlQN0FPUUs3LU84VVNPc1dtTXR1bjA?oc=5\" target=\"_blank\">Amgen Stock (AMGN) Opinions on Dividend Announcement and Clinical Trial Success</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Quiver Quantitative</font>",
      "published": "2025-08-23T14:05:00+00:00",
      "source": "Quiver Quantitative"
    },
    {
      "title": "Amgen Inc. $AMGN Shares Acquired by Sumitomo Mitsui Financial Group Inc. - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPMklYNUVsWng0ZWV5ajdBT2FvTmNWVVU0UFpLUGxUVnFBT1BHcnFMTXc5QjBnd3F1WWZDVHVxWlNQaFVNZHUtc3cxSko1SGg1ekRKdkVNT0tTRlVzRzNsQmdrVDVNeGFfVVFMUGRxdGRTOTVEUUhQMUc2VnQ5M29hZl9WYkdndFRWZW5ZY1l3a0pzLS1BdGtYN3ZYU201S201eEIyelhDQWhHdGxZVmUxMFdLZVpJR0RfWmVJY25qbEYzcWNSemZxLVVB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxPMklYNUVsWng0ZWV5ajdBT2FvTmNWVVU0UFpLUGxUVnFBT1BHcnFMTXc5QjBnd3F1WWZDVHVxWlNQaFVNZHUtc3cxSko1SGg1ekRKdkVNT0tTRlVzRzNsQmdrVDVNeGFfVVFMUGRxdGRTOTVEUUhQMUc2VnQ5M29hZl9WYkdndFRWZW5ZY1l3a0pzLS1BdGtYN3ZYU201S201eEIyelhDQWhHdGxZVmUxMFdLZVpJR0RfWmVJY25qbEYzcWNSemZxLVVB?oc=5\" target=\"_blank\">Amgen Inc. $AMGN Shares Acquired by Sumitomo Mitsui Financial Group Inc.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-08-24T09:56:45+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Is it too late to sell Amgen Inc. - Weekly Stock Recap & Accurate Buy Signal Alerts - Newser",
      "link": "https://news.google.com/rss/articles/CBMickFVX3lxTE9aMlUxdmoyd3Jianh3X1oycDFwZE93ZFktQk9SeFRfb0ZHVWhlWUZZbzFNeFR3blNvek03YlFGSllOMlQ4RHhkRXU4UkNONlFTWGZoSGM1X040VkxoSjhpQ3VhUFdKR1BUeF94YjUxeDJ4dw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMickFVX3lxTE9aMlUxdmoyd3Jianh3X1oycDFwZE93ZFktQk9SeFRfb0ZHVWhlWUZZbzFNeFR3blNvek03YlFGSllOMlQ4RHhkRXU4UkNONlFTWGZoSGM1X040VkxoSjhpQ3VhUFdKR1BUeF94YjUxeDJ4dw?oc=5\" target=\"_blank\">Is it too late to sell Amgen Inc. - Weekly Stock Recap & Accurate Buy Signal Alerts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>",
      "published": "2025-08-23T13:00:35+00:00",
      "source": "Newser"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5\" target=\"_blank\">Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Amgen Confirms Launch Of First US Eculizumab Rival - insights.citeline.com",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5\" target=\"_blank\">Amgen Confirms Launch Of First US Eculizumab Rival</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>",
      "published": "2025-03-05T08:00:00+00:00",
      "source": "insights.citeline.com"
    },
    {
      "title": "Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5\" target=\"_blank\">Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2025-04-14T07:00:00+00:00",
      "source": "FirstWord Pharma"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "UK court clears the way for Amgen and Samsung to launch biosimilars - Life Sciences Intellectual Property Review",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPWkdPRDN3S2JyejdQMF9Dcnlud3hwb0pIaV9BUXBpdE54cW9DUVltNzRNcVM2UjBhd2lCZXc3YXFCR1Zaa2lIdHA5dVJqMFpTa2FPU1Z6Tjh1VVg5aFotTG4xSVdwNGt4OGJ5WXlHSjN4VTJ1a1lPYzMxVFBLeTJ4Z010Z3d4anpvYV9YYkpxczNBLVJkX3I2UVBLOEVUc1hmX3kwbG9KZnZnd2ZBMGt4Qg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxPWkdPRDN3S2JyejdQMF9Dcnlud3hwb0pIaV9BUXBpdE54cW9DUVltNzRNcVM2UjBhd2lCZXc3YXFCR1Zaa2lIdHA5dVJqMFpTa2FPU1Z6Tjh1VVg5aFotTG4xSVdwNGt4OGJ5WXlHSjN4VTJ1a1lPYzMxVFBLeTJ4Z010Z3d4anpvYV9YYkpxczNBLVJkX3I2UVBLOEVUc1hmX3kwbG9KZnZnd2ZBMGt4Qg?oc=5\" target=\"_blank\">UK court clears the way for Amgen and Samsung to launch biosimilars</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Life Sciences Intellectual Property Review</font>",
      "published": "2025-05-22T07:00:00+00:00",
      "source": "Life Sciences Intellectual Property Review"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-08-22",
      "close": 293.7200012207031
    },
    "history": [
      {
        "date": "2025-08-14",
        "close": 287.95404052734375
      },
      {
        "date": "2025-08-15",
        "close": 294.08428955078125
      },
      {
        "date": "2025-08-18",
        "close": 290.2652587890625
      },
      {
        "date": "2025-08-19",
        "close": 293.17169189453125
      },
      {
        "date": "2025-08-20",
        "close": 294.064453125
      },
      {
        "date": "2025-08-21",
        "close": 293.3800048828125
      },
      {
        "date": "2025-08-22",
        "close": 293.7200012207031
      }
    ],
    "name": "Amgen Inc."
  }
}